Skip to main content
OpenTrials
Completed

NCT Number: NCT06786013

Effects of Interscalene Block on Visual Clarity in Arthroscopic Surgery

Arthroscopic rotator cuff repair (RCR) has become the predominant technique for managing patients with full-thickness rotator cuff tears. Optimizing visual clarity is crucial for performing shoulder arthroscopy safely, precisely, and successfully. However, intraoperative bleeding remains the most significant factor impairing visual clarity.

The interscalene brachial plexus block (ISB) technique is widely employed in shoulder joint and upper extremity surgeries. However, ISB may lead to hypertension due to the spread of local anesthetic to adjacent structures, such as the carotid sinus baroreceptors. Hypertension-induced microbleeding can obstruct the surgical field of view.

Our hypothesis suggests that arthroscopic visual clarity may be compromised in awake patients receiving ISB for anesthesia.

This study aims to compare the effects of interscalene brachial plexus block and general anesthesia on hemodynamic parameters and visual clarity in patients undergoing arthroscopic rotator cuff repair surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Alper Kilicaslan

Konya, Turkey (Türkiye)

About this study

Our study will be conducted prospectively, and no additional medication or interventional procedure will be administered to the patients. A total of 80 patients, 40 from the general anesthesia group and 40 from the interscalene block anesthesia group, who meet the inclusion criteria, will be included in the study. In both groups, systolic arterial blood pressure (SAB), diastolic arterial blood pressure (DAB), mean arterial blood pressure (MAP), and heart rate (HR) values will be recorded every 5 minutes throughout the operation after the surgical procedure begins. At the end of the operation, visual clarity will be assessed by the same surgeon (M.O) using a Numeric Rating Scale (0 = very poor, 10 = excellent). To detect a 2-point (20%) difference in the NRS score for visual clarity, a total of 37 patients are required with 80% power and a significance level of 0.05. This calculation assumes that such an effect is clinically significant and that the standard deviation is 2.21. Assuming a 10% dropout rate, we calculated that a total of 80 patients would be needed for two groups, with 40 patients per group.

Descriptive statistics, including mean, standard deviation, median, minimum, maximum, frequency, and percentage, will be used to summarize the data. The Kolmogorov-Smirnov test will be employed to assess the distribution of variables. For the comparison of quantitative data, the Independent Samples t-test and Mann-Whitney U test will be utilized. For the comparison of qualitative data, the Chi-Square test will be used. A p-value less than 0.05 will be considered statistically significant.

The cut-off values of quantitative parameters will be determined using ROC analysis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients able to provide informed consent.
  • Patients able to reliably report their symptoms to the research team.
  • ASA physical status classification of 1-3.
  • Scheduled to undergo arthroscopic rotator cuff repair surgery in the lateral decubitus position.

Exclusion criteria

  • Contraindications to anesthesia.
  • Patients under 18 years old.
  • Cognitive impairment or communication barriers.
  • BMI > 40.
  • Weight less than 50 kg or more than 100 kg.
  • Psychiatric disorders.
  • Chronic opioid therapy for pain.
  • Severe liver, heart, or kidney failure.
  • Hypertension (possibly severe, depending on the study context).
  • Use of opioids for any reason.
  • Revision shoulder surgery.
  • Diaphragmatic paralysis on the opposite side of the planned intervention.
  • Concurrent anticoagulation therapy or coagulopathy.
  • Skin deformities or infections in the block area.
  • Progressive neurological deficits affecting peripheral nerves.
  • Allergy to amide-structured local anesthetics.
  • ASA physical classification score ≥4.
  • Suspected or confirmed pregnancy.
  • Breastfeeding mothers.
  • Patients who do not consent to participate in the study.

Treatment and study plan

Primary outcomes

  1. Visual clarity during arthroscopic rotator cuff repair

    Time frame: 1 day

    Visual clarity of the arthroscopic view will be assessed by the same surgeon (MO) using a Numeric Rating Scale (0 = very poor, 10 = excellent).

Secondary outcomes

  1. Hemodynamic parameters

    Time frame: 1 day

    systolic arterial blood pressure (mm Hg), diastolic arterial blood pressure (mm Hg), mean arterial blood pressure (mm Hg), and heart rate (beats per minute) values will be recorded every 5 minutes after IS block and throughout the surgery pressure (mm/Hg), and heart rate (beats per minute) values will be recorded every 5 minutes throughout the operation

  2. Visual analog scale (VAS) pain scores

    Time frame: at 6,12, 18, 24 hours postoperatively

    Pain was evaluated by blinded researcher using visual analog scale (VAS) pain scores

Sponsors and collaborators

Lead sponsor

Konya Necmettin Erbakan Üniversitesi

Other

Registry information

Official study title

Effects of Interscalene Block Anesthesia on Visual Clarity and Hemodynamic Parameters in Arthroscopic Rotator Cuff Repair: A Prospective, Randomized Study

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jan 22, 2025
Registry last updated
Dec 23, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.